UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma

The oncologist (Dayton, Ohio), 2009-01, Vol.14 (1), p.95-100

2009

Link zum Volltext

Verfügbarkeit prüfen

Bayesian Methods in Human Drug and Biological Products Development in CDER and CBER

Therapeutic innovation & regulatory science, 2023-05, Vol.57 (3), p.436-444

2023

Link zum Volltext

Verfügbarkeit prüfen

Approval Summary: Erlotinib Maintenance Therapy of Advanced/Metastatic Non‐Small Cell Lung Cancer (NSCLC)

The oncologist (Dayton, Ohio), 2010-12, Vol.15 (12), p.1344-1351

2010

Link zum Volltext

Verfügbarkeit prüfen

Composite model of time-varying appearance and disappearance of neurohormone pulse signals in blood

Journal of theoretical biology, 2005-10, Vol.236 (3), p.242-255

2005

Link zum Volltext

Verfügbarkeit prüfen

On Bayesian Analysis and Hypothesis Testing in the Determination of Bioequivalence

Clinical pharmacology and therapeutics, 2019-02, Vol.105 (2), p.304-306

2019

Link zum Volltext

Verfügbarkeit prüfen

First FDA Approval of Dual Anti-HER2 Regimen: Pertuzumab in Combination with Trastuzumab and Docetaxel for HER2-Positive Metastatic Breast Cancer

Clinical cancer research, 2013-09, Vol.19 (18), p.4911-4916

2013

Link zum Volltext

Verfügbarkeit prüfen

Statement on P-values

Statistics in biopharmaceutical research, 2021-02, Vol.13 (1), p.57-58

2021

Link zum Volltext

Verfügbarkeit prüfen

PROBABILISTIC RECOVERY OF NEUROENDOCRINE PULSATILE, SECRETORY AND KINETIC STRUCTURE: AN ALTERNATING DISCRETE AND CONTINUOUS SCHEME

Quarterly of applied mathematics, 2008-01, Vol.66 (3), p.401-421

2008

Link zum Volltext

Verfügbarkeit prüfen

PROBABILISTIC RECOVERY OF NEUROENDOCRINE PULSATILE, SECRETORY AND KINETIC STRUCTURE : AN ALTERNATING DISCRETE AND CONTINUOUS SCHEME

Quarterly of applied mathematics, 2008, Vol.66 (3), p.401-421

2008

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous hormone pulse time and secretion /elimination estimation: An alternating metropolis and diffusion scheme

Chattopadhyay, Somesh

2001

Link zum Volltext
ProQuest

Statistical Monitoring of Clinical Trials: A Unified Approach

Journal of the American Statistical Association, 2008, Vol.103 (481), p.430-431

2008

Link zum Volltext

Verfügbarkeit prüfen

Statistical Monitoring of Clinical Trials: A Unified Approach

Journal of the American Statistical Association, 2008, Vol.103 (481), p.430-431

2008

Link zum Volltext

Verfügbarkeit prüfen

Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells

Cancers, 2022-09, Vol.14 (18), p.4496

2022

Link zum Volltext

Verfügbarkeit prüfen

T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo

Clinica chimica acta, 2013-09, Vol.424, p.27-32

2013

Link zum Volltext

Verfügbarkeit prüfen

Participation of T cell immunoglobulin and mucin domain-3 (TIM-3) and its ligand (galectin-9) in the pathogenesis of active generalized vitiligo

Immunologic research, 2015-05, Vol.62 (1), p.23-34

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(15)

Publikationsform

Sprache

Englisch
(16)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(12)
Life Sciences & Biomedicine
(11)
Humans
(8)
Oncology
(5)
United States
(5)
United States Food And Drug Administration
(5)
Drug Approval
(4)
Female
(4)
Biological And Medical Sciences
(3)
Male
(3)
Mathematics
(3)
Adult
(2)
Antineoplastic Agents
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Cancer Research
(2)
Clinical Trials
(2)
Kinetics
(2)
Mathematical & Computational Biology
(2)
Medical Sciences
(2)
Pharmacology & Pharmacy
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma

Bayesian Methods in Human Drug and Biological Products Development in CDER and CBER

Approval Summary: Erlotinib Maintenance Therapy of Advanced/Metastatic Non‐Small Cell Lung Cancer (NSCLC)

Composite model of time-varying appearance and disappearance of neurohormone pulse signals in blood

On Bayesian Analysis and Hypothesis Testing in the Determination of Bioequivalence

Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval Summary

First FDA Approval of Dual Anti-HER2 Regimen: Pertuzumab in Combination with Trastuzumab and Docetaxel for HER2-Positive Metastatic Breast Cancer

Statement on P-values

PROBABILISTIC RECOVERY OF NEUROENDOCRINE PULSATILE, SECRETORY AND KINETIC STRUCTURE: AN ALTERNATING DISCRETE AND CONTINUOUS SCHEME

PROBABILISTIC RECOVERY OF NEUROENDOCRINE PULSATILE, SECRETORY AND KINETIC STRUCTURE : AN ALTERNATING DISCRETE AND CONTINUOUS SCHEME

Simultaneous hormone pulse time and secretion /elimination estimation: An alternating metropolis and diffusion scheme

Statistical Monitoring of Clinical Trials: A Unified Approach

Statistical Monitoring of Clinical Trials: A Unified Approach

Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells

T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo

Participation of T cell immunoglobulin and mucin domain-3 (TIM-3) and its ligand (galectin-9) in the pathogenesis of active generalized vitiligo

Suchergebnisse filtern